Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Luminal A Early Breast Cancer

NCT02889874 is registered in ClinicalTrials.gov with Breast Cancer Trials, Australia and New Zealand as lead sponsor.

NCT NCT02889874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02889874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following Breast Conserving Surgery and Endocrine Therapy in Patients With Molecularly Characterised Luminal A Early Breast Cancer
Lead sponsor
Breast Cancer Trials, Australia and New Zealand
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 21, 2017
Completion date
April 30, 2028
Enrollment
1,167 (estimated)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

early stage breast carcinoma